Skip to main content
AJNR: American Journal of Neuroradiology logoLink to AJNR: American Journal of Neuroradiology
. 2010 Jun-Jul;31(6):1106–1112. doi: 10.3174/ajnr.A2000

Atherosclerotic Carotid Stenoses of Apical versus Body Lesions in High-Risk Carotid Stenting Patients

S-T Park a,d, JK Kim e, KH Yoon f, S-O Park a, SW Park b, JS Kim c, SJ Kim a, DC Suh a,
PMCID: PMC7963931  PMID: 20093309

Abstract

BACKGROUND AND PURPOSE:

Different lesion locations in the atherosclerotic carotid bulb stenosis have not been clearly defined. We sought to evaluate 2 locations of carotid bulb stenosis in high-risk patients and to determine the relationship of each location to atherosclerotic risk factors and clinical features.

MATERIALS AND METHODS:

Atherosclerotic carotid plaques of apical versus body lesions, defined according to the area and extent of plaque involvement, were retrospectively analyzed in 200 consecutive high-risk patients who underwent carotid stent placement because of ≥50% symptomatic stenosis. We evaluated interobserver concordance and assessed each type of lesion relative to 13 atherosclerotic risk factors, mode of symptom presentation, infarct pattern, procedure-related factors, and clinical outcomes, by univariate and multivariable logistic regression analysis.

RESULTS:

Interobserver concordance showed good agreement for differentiating apical and body lesions (κ = 0.745). Univariate analysis revealed that apical lesions (n = 108, 54%) were associated with pseudo-occlusion (P = .027), older age (P = .073), and alcohol intake (P = .080), whereas body lesions (n = 92, 46%) were associated with hyperlipidemia (P = .001), a wedge-shaped cortical infarct pattern (P = .057), and hyperperfusion syndrome (P = .083). Multivariable logistic regression analysis adjusted by age revealed that hyperlipidemia (P = .002; OR, 3.462; 95% CI, 1.595–7.515) and hyperperfusion (P = .026; OR, 6.727; 95% CI, 1.261–35.894) were independent predictors of body-type lesions.

CONCLUSIONS:

Atherosclerotic carotid bulb stenosis was found to have 2 distinct locations, body and apical. Hyperlipidemia and cortical wedge-shaped infarcts were more frequently associated with body than with apical stenosis at the time of presentation.


The carotid bulb, the focally enlarged vascular structure just distal to the bifurcation of the CCA, is the major site of involvement in atherosclerotic stenosis.1 Vessel segments with low WSS and resultant flow stagnation at the carotid bulb appear to be at highest risk for development of atherosclerosis.2 Together with the condition of low WSS, a large lipid pool contributes to development of vulnerable plaque.3

Although high shear stress was initially reported to cause atherosclerosis,4 the involvement of low WSS associated with hemodynamic parameters such as the WSS temporal gradient and cyclic strain high in the carotid bulb have more recently been associated with the formation of atherosclerosis.5 Men are more likely than women to develop maximum stenosis distal to the carotid bulb because of differences in absolute vessel size and the relative area of the ICA outflow compared with the CCA.6

We experienced 2 different patterns of plaque development in the carotid bulb in Korean patients. However, few reports on incidence, clinical features, or atherosclerotic risk factors have appeared. We therefore hypothesized that there are 2 different lesion locations in the carotid bulb, which may have distinct cardiovascular risk factors, presenting patterns, and clinical courses. Based on the morphologic definition of 2 locations of carotid bulb stenosis, we assessed their association with 13 atherosclerotic vascular risk factors, mode of symptom presentation, infarct patterns, procedure-related factors, and clinical outcomes.

Materials and Methods

We performed a retrospective analysis of 200 consecutive patients (men-to-women ratio, 165:35; mean age, 68 years; range, 42–87 years) who underwent carotid stent placement between March 2002 and September 2008 and from whom data were collected prospectively. Patients were included if they had symptomatic carotid stenosis ≥50% according to NASCET criteria, whereby the diameter at the most stenotic point is compared with the reference diameter of the distal ICA beyond the narrowing and the poststenotic dilation.7 All patients were at high medical and surgical risk for carotid endarterectomy.810 The major eligibility criteria for high-risk patients are listed in Table 1. All patients were required to have at least one coexisting condition that potentially increased the risk posed by carotid endarterectomy.

Table 1:

Criteria for high-risk patients

Clinically significant cardiac disease
    Congestive heart failure (New York Heart Association functional class III/IV)
    Abnormal stress test
    Need for open-heart surgery
    Unstable angina (Canadian Cardiovascular Society class III/IV)
    Left ventricular ejection fraction ≤30%
    Planned coronary artery bypass graft or valve replacement
Severe pulmonary disease
    Chronic obstructive pulmonary disease manifested with FEV ≤30%
Contralateral carotid occlusion or stenosis
Previous radical neck surgery or radiation therapy to the neck
Recurrent stenosis after endarterectomy
Age ≥75 years
Surgically inaccessible lesion at or above C2, or below clavicle
Laryngeal palsy or laryngectomy
Symptom onset within 2 weeks
Neurologic symptoms (National Institutes of Health Stroke Scale grade ≥4) within 48 hours from onset
Arteriosclerosis obliterans
Cancer
History of major surgery within the past year
Renal problems (creatinine level >1.5 mg/dL)

We excluded patients with 1) nonatherosclerotic arterial diseases such as Takayasu arteritis and dissection, 2) acute symptom onset within 6 hours, and 3) stent placement following intra-arterial thrombolysis and/or angioplasty. This study was approved by our institutional review board.

Angiographic Analysis of the Carotid Bulb

The anatomic definitions are illustrated in Fig 1, with atheromatous plaque involvement of the carotid bulb categorized as an apical or body lesion (Figs 2 and 3).5,6,11 Apical lesions were those in which the transitional zone of the bulb and the proximal cervical ICA segment (ie, the apical segment) were affected by plaque without or with minimal involvement of the body segment (Fig 2). Body lesions were those in which the transitional zone of the CCA and the bulb were affected by plaque located mainly in the body segment, thus causing the most severe stenosis at the body (Fig 3). We regarded involvement of the transitional zone between the CCA and the bulb, the most commonly involved site of atherosclerosis in the carotid bulb, as the most important differential point.12 Additionally, the main involvement area of plaque and the most severe stenosis were differentiated.

Fig 1.

Fig 1.

Anatomic definition of the carotid bulb.

Fig 2.

Fig 2.

A 76-year-old man with an apical carotid bulb lesion detected before coronary artery bypass surgery. Brain MR imaging was normal (not shown). There was an apical form of severe stenosis in the carotid bulb. There was no carotid sinus reaction during the procedure.

Fig 3.

Fig 3.

A 72-year-old woman with the body type of carotid bulb lesion presenting with right arm weakness and dysarthria occurring 20 days earlier. Body-type lesion in the right carotid bulb. There was a marked carotid sinus reaction during carotid stent placement.

As plaque enlargement is regarded as an extended form of plaque, we defined an extended apical lesion as one in which apical plaque involved the body of the carotid bulb (Fig 4) and an extended body type of plaque as one in which the body plaque involved the apex (Fig 5). The main component with plaque involvement and the level of the most severe stenosis were considered as part of the extent of plaque for differentiation of the extended types. Each was distinguished by assessing at least 2 projections of the common carotid arterial injections. Two experienced neuroradiologists (S.J.K. and S.-T.P.), who were not involved in stent placement procedures and who were blinded to names, clinical histories, brain imaging data, and examination dates, independently reviewed all images, and interobserver agreement in lesion classifications was determined.

Fig 4.

Fig 4.

Extended apical type stenosis. A diffuse plaque extends to the bulb area (A) and/or reveals ulceration (arrow) (B).

Fig 5.

Fig 5.

Extended bulb type stenosis. A primary bulb lesion extends to the apex with ulcerative bulb plaque (A) and ulceration associated with a luminal filling defect (arrow) (B).

As the mean carotid bulb lesion length in our patients was 20 mm, we used this as the lesion length cutoff point. The degree of stenosis was classified as 50%–69%, 70%–79%, 80%–89%, 90%–94%, or as a pseudo-occlusion (>95%). Collateral circulation on angiography was evaluated by using Thrombolysis in Cerebral Infarction grading.13

Analysis of Cardiovascular Risk Factors

All variables were dichotomized for statistical analysis, including age (>67 years vs ≤67 years), sex (male vs female), hypertension (blood pressure >140/90 mmHg), diabetes mellitus (fasting blood sugar level >126 mg/dL, postprandial 2-hour blood sugar level >200 mg/dL), hyperlipidemia (total cholesterol ≥220 mg/dL or LDL ≥130 mg/dL), smoking (currently smoking or ex-smoker for <6 months), homocysteine level (≥15 μmol/L),14 high-sensitivity C-reactive protein concentration (≥0.6 mg/dL),15 and body mass index (≥25 kg/m2).16

Analysis of Symptom Presentation and MR Imaging Infarct Patterns

The severity of initial symptoms was evaluated by using the NIHSS.17 The presenting symptom pattern of each patient was classified as a transient ischemic attack, stroke, or no symptoms. The symptom onset period before the stent placement procedure was classified as within 1 day, 1 week, 1 month, or >1 month.

All patients underwent brain MR imaging examination before carotid stent placement. Cerebral ischemic changes or infarctions on MR imaging at the time of symptom presentation were classified according to the lesion distribution of high-signal intensities on diffusion- or T2-weighted images.18,19 The topography of each ischemic lesion was determined by using published templates and classified as a cortical wedge or territorial infarct, a perforator infarct, or a border-zone infarct.18 All parenchymal lesions were classified according to their longest dimension as large (>20 mm), medium (10–20 mm), and small (<10 mm). Lesion number was classified as 1 or multiple.

Procedure-Related Factors and Clinical Outcomes

Procedure-related factors included the type of stent (ie, open vs closed) and use of a protection device. Hemodynamic disturbances during and after stent placement included periprocedural hypotension (systolic blood pressure <90 mm Hg), bradycardia (heart rate <50 beats/s), heart rate fluctuation (>20 beats/s), and hypertension (>160 mm Hg). Hyperperfusion was diagnosed when MR imaging showed increased perfusion in the brain vascular territory, corresponding to the development of symptoms within 1 month after stent placement, or a hemorrhage in the ipsilateral vascular territory not otherwise explained.

Patients were followed up by Doppler ultrasonography or cerebral angiography 6–12 months after the procedure. Restenosis (>50%) was defined as a reduction in the luminal diameter by using NASCET criteria on cerebral angiography, or by using B-mode sonography and/or peak systolic velocity (>300 cm/s or >4-fold the ICA/CCA ratio) on Doppler sonography.20 Events after stent placement included minor stroke, major stroke, or death. Minor stroke was defined as a new, nondisabling neurologic deficit or a 3-point increase in the NIHSS, either of which completely resolved within 30 days.21 Major stroke was defined as a new neurologic deficit with a 4-point increase in NIHSS persisting for >30 days. The final outcome at 6 months was determined by using the mRS, with good outcome scoring ≤2 and poor outcomes ≥3.22

Statistical Analysis

Interobserver agreement on angiographic lesion location (ie, apical vs body) was assessed by using Cohen κ statistics. Lesion location was regarded as a dependent variable. We extracted explanatory variables from risk factors and angiographic results. Univariate analysis, by using the χ2 or Fischer exact test, was performed to determine the association between lesion location and the explanatory variables. Continuous variables were converted to nominal variables according to median or mean values. Explanatory variables showing P values <.1 on univariate analysis were selected for multivariable logistic regression analysis, which evaluated interaction among the explanatory variables. All P values were calculated by using the 2-tailed test. A P value of <.05 was considered significant. Calculations were performed by using SPSS 14.0 for Windows (SPSS, Chicago, Illinois)

Results

Angiographic Analysis of the Carotid Bulb

Interobserver concordance showed good agreement for differentiating lesions in the apex and body of the carotid bulb (κ = 0.745). Of the 200 patients, 108 had apical and 92 had body lesions. Pseudo-occlusion showed significant association with the apical type (P = .027) on univariate analysis. The length of stenosis and collateral circulation was not associated with either type. Bilateral lesions were identified in 29 patients (15%). The concordance rate of the same type of lesion in patients with bilateral stenosis was 90%. Of the 50 extended lesions in 45 patients (23%), 33 were apical and 17 were of the bulb type. When extended lesions were excluded, interobserver concordance also showed good agreement (κ = 0.798).

Analysis of Cardiovascular Risk Factors

Univariate analysis of 13 atherosclerotic cardiovascular risk factors showed a significant association between hyperlipidemia and body-type lesions (P = .001, Table 2). Age (P = .073) and alcohol consumption (P = .080) were marginally related to apical-type lesion occurrence.

Table 2:

Demographic features and cardiovascular risk factors

Apical Lesion (n = 108) Body Lesion (n = 92) P Value
Age (>67 years) 63 42 .073
Gender (male) 91 74 .478
Hypertension (presence) 80 72 .490
Diabetes mellitus (presence) 43 35 .798
Cardiac disease (presence) 33 21 .220
Hyperlipidemia (presence) 12 28 .001
Family history (presence) 20 17 .994
Previous stroke history (presence) 32 32 .436
Smoking (yes) 38 35 .676
Alcohol use (yes) 58 38 .080
Homocysteine (≥15 μmol/L) 34 32 .948
High-sensitivity C-reactive protein (≥0.6 mg/dL) 31 26 .857
Body mass index (≥25) 34 30 .865

Analysis of Symptom Presentation and MR Imaging Infarct Patterns

Presenting symptom patterns, including severity, presentation, and symptom onset to procedure, were not associated with either type of lesion. Assessment of brain parenchymal infarct pattern at the time of symptom presentation showed a significant association between cortical-wedge infarcts and body-type lesions (P = .057, Fig 3 and Table 3).

Table 3:

Factors related to brain infarcts

Apical Lesion (n = 56) Body Lesion (n = 55) P Value
Infarct pattern .057
    Cortical wedge/territorial lesion 13 22
    Others 43 33
Infarct size .245
    Large (≥20 mm) 15 21
    Medium (10–20 mm) 13 7
    Small (<10 mm) 28 27
Number of infarcts .167
    Single 14 8
    Multiple 42 47

Procedure-Related Factors and Clinical Outcomes

Closed-cell-type stents and protection devices were more frequently used for body than for apical lesions. These procedure-related factors were at the discretion of individual operators. Hyperperfusion syndrome (P = .083) was marginally related to body lesion occurrence, whereas frequent carotid sinus reactions were not (P = .228, Table 4).

Table 4:

Factors related to stenting procedure and clinical outcomes after procedure

Apical Lesion (n = 108) Body Lesion (n = 92) P Value
Carotid sinus reaction 68 65 .228
Hyperperfusion syndrome 2 7 .083
Restenosis at 6 months 6 5 1.000
Events within 6 months 12 9 .746

Six-month follow-up mRS, restenosis, and events, as well as mRS after the procedure, were not associated with either lesion type (Table 4).

Multivariable Logistic Regression Analysis

Explanatory variables showing P values of <.1 on univariate analysis included hyperlipidemia (P = .001), pseudoocclusion (P = .027), alcohol use (P = .080), age (P = .073), and hyperperfusion syndrome (P = .083). Multivariable logistic regression analysis adjusted by age showed that hyperlipidemia (P = .002; OR, 3.462; 95% CI, 1.595–7.515) and hyperperfusion (P = .026; OR, 6.727; 95% CI, 1.261–35.894) were independent predictors of body-type lesions.

Discussion

The subtyping of atherosclerotic carotid stenosis is supported by some clinical factors. Whereas body lesions are more frequent than are apical lesions in patients with hyperlipidemia and postprocedural hyperperfusion syndrome, apical lesions are more frequent in older patients and those with pseudoocclusions. The association between hyperlipidemia and body lesion corresponds to the classic pathogenesis of atherosclerotic plaque in the carotid bulb, especially in the body portion of the hemodynamically low WSS area.3

The posterior wall of the carotid bulb (ie, the focally enlarged vascular structure just distal to the bifurcation of the CCA) is the primary site of involvement of atherosclerotic stenosis. Embryologically, the cervical ICA at the common carotid bifurcation, the bulb, and the CCA originate from the third aortic arch.23,24 Despite the body being the most common site of atherosclerotic involvement, we found that carotid stenosis affected the apex to an extent similar to that of the body. This may be attributable to ethnic factors. Our study included only Korean patients; thus, the ratio of apical-to-body stenosis may differ in other populations, including Western patients. There may be a greater tendency toward apical-type lesions in Koreans, as bulb-type lesions are more common in Western populations and carotid stenosis is less common than is intracranial stenosis in Koreans.25 There may also be racial/ethnic differences in the anatomy of the carotid bifurcation, in that African Americans were found to have a proportionally smaller ICA and a larger ECA than did whites or Caribbean Hispanics.26 Thus, hemodynamic factors,5 as well as sex differences in carotid bifurcation anatomy and the distribution of atherosclerotic plaque,6 suggest that the 2 distinct locations of carotid bulb stenosis may correspond to 2 different flow mechanisms, low WSS in the body type and high WSS in the apical type.

Although previous hemodynamic studies assumed that low WSS caused atherosclerosis in the carotid bulb, the role of high WSS in atherosclerosis is unclear, and high WSS may or may not be a causative factor (Fig 6).2,4 Low WSS is thought to induce plaques, whereas high WSS is considered to be involved in the shear stress that causes plaque rupture.2,27,28 The presence of an atherosclerotic lesion in the body of the carotid bulb can be explained by classical hemodynamic theory, that is, a low WSS in conjunction with hyperlipidemia.3 Alternatively, the apex of the carotid bulb has been found to have 2 other characteristic hemodynamic factors, a high WSS temporal gradient and an elevated degree of cyclic strain, both of which are involved in atherosclerosis.11,29,30 Additional clinical and hemodynamic studies may be needed to determine the exact causes and possible mechanisms underlying the differences seen.

Fig 6.

Fig 6.

Concept diagram of carotid bulb lesion type; the apical and body lesions.

Our results suggest that stenosis location may affect the frequency of the carotid sinus reaction triggered by stimulation of the carotid baroreceptor in the carotid body, reducing the sympathetic tone and increasing vagal activity, resulting in a decrease in blood pressure and heart rate.31,32 The distance between the carotid bifurcation and the maximum stenotic lesion (≤10 mm) was reported to be an independent risk factor for carotid artery stent placement in 31 patients, as lesions with maximum stenosis >10 mm from the carotid bifurcation were associated with a low incidence of hypotension.33 Hyperperfusion syndrome34 occurred frequently in our patients with body-type lesions, suggesting that the carotid body has a hemodynamic effect on the ipsilateral cerebral circulation.

Several attempts have been made to document anatomic differences attributable to age and sex. The ICA, relative to both the ECA and the CCA, is larger in women than in men, suggesting that men are more likely to show maximum stenosis distal to the carotid bulb, thus at the apex, whereas women are more likely to present with stenosis of the ECA.6 However, the cited study excluded patients with severe (>50%) stenosis on NASCET (identical to >70% on European Carotid Surgery Trial), because of the resulting secondary deformity.6,35 We observed no difference by sex in the site of stenosis, suggesting that the earlier distinction may have been unique to the cohort evaluated.

Conclusions

We found that atherosclerotic carotid bulb stenosis tended to occur in 2 distinct locations, body and apical. The latter lesions were associated with pseudo-occlusion, older age, and alcohol intake, whereas body lesions were accompanied by hyperlipidemia, a wedge-shaped cortical infarct pattern, and hyperperfusion syndrome.

Acknowledgments

We acknowledge the assistance of Sun Moon Whang and Eun Hye Kim in patient data collection, and Yun Gyeong Jeong for manuscript preparation. We thank Bonnie Hami for her English editorial assistance.

Abbreviations

CCA

common carotid artery

CI

confidence interval

ECA

external carotid artery

FEV

forced expiratory volume

ICA

internal carotid artery

mRS

modified Rankin scale

OR

odds ratio

NASCET

North American Symptomatic Carotid Endarterectomy Trial

NIHSS

National Institutes of Health Stroke Scale

WSS

wall shear stress

Footnotes

This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A080201).

References

  • 1. Pujia A, Rubba P, Spencer MP. Prevalence of extracranial carotid artery disease detectable by echo-Doppler in an elderly population. Stroke 1992;23:818–22 [DOI] [PubMed] [Google Scholar]
  • 2. Shaaban AM, Duerinckx AJ. Wall shear stress and early atherosclerosis: a review. AJR Am J Roentgenol 2000;174:1657–65 [DOI] [PubMed] [Google Scholar]
  • 3. Cheng C, Tempel D, van Haperen R, et al. Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. J Clin Invest 2007;117:616–26 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Fry DL. Certain histological and chemical responses of the vascular interface to acutely induced mechanical stress in the aorta of the dog. Circ Res 1969;24:93–108 [DOI] [PubMed] [Google Scholar]
  • 5. Younis HF, Kaazempur-Mofrad MR, Chan RC, et al. Hemodynamics and wall mechanics in human carotid bifurcation and its consequences for atherogenesis: investigation of inter-individual variation. Biomech Model Mechanobiol 2004;3:17–32 [DOI] [PubMed] [Google Scholar]
  • 6. Schulz UG, Rothwell PM. Sex differences in carotid bifurcation anatomy and the distribution of atherosclerotic plaque. Stroke 2001;32:1525–31 [DOI] [PubMed] [Google Scholar]
  • 7. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445–53 [DOI] [PubMed] [Google Scholar]
  • 8. White CJ, Iyer SS, Hopkins LN, et al. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv 2006;67:503–12 [DOI] [PubMed] [Google Scholar]
  • 9. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–501 [DOI] [PubMed] [Google Scholar]
  • 10. Suh DC, Kim JK, Choi JW, et al. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol 2008;29:781–85 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Salzar RS, Thubrikar MJ, Eppink RT. Pressure-induced mechanical stress in the carotid artery bifurcation: a possible correlation to atherosclerosis. J Biomech 1995;28:1333–40 [DOI] [PubMed] [Google Scholar]
  • 12. Sundberg J. Localisation of atheromatosis and calcification in the carotid bifurcation: a post mortem radiographic investigation. Acta Radiol Diagn (Stockh) 1981;22:521–28 [DOI] [PubMed] [Google Scholar]
  • 13. Higashida RT, Furlan AJ. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–37 [DOI] [PubMed] [Google Scholar]
  • 14. Coull BM, Malinow MR, Beamer N, et al. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990;21:572–76 [DOI] [PubMed] [Google Scholar]
  • 15. Yeh ETH, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation 2003;107:370–71 [DOI] [PubMed] [Google Scholar]
  • 16. Balkau B, Valensi P, Eschwege E, et al. . A review of the metabolic syndrome. Diabetes Metab 2007;33:405–13 [DOI] [PubMed] [Google Scholar]
  • 17. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4–11 [DOI] [PubMed] [Google Scholar]
  • 18. Lee DK, Kim JS, Kwon SU, et al. Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke 2005;36:2583–88 [DOI] [PubMed] [Google Scholar]
  • 19. Lee PH, Oh SH, Bang OY, et al. Isolated middle cerebral artery disease: clinical and neuroradiological features depending on the pathogenesis. J Neurol Neurosurg Psychiatry 2004;75:727–32 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Setacci C, Chisci E, Setacci F, et al. Grading carotid intrastent restenosis: a 6-year follow-up study. Stroke 2008;39:1189–96 [DOI] [PubMed] [Google Scholar]
  • 21. Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale: extension to non-neurologists in the context of a clinical trial. Stroke 1997;28:307–10 [DOI] [PubMed] [Google Scholar]
  • 22. Sulter G, Steen C, Jacques De K. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30:1538–41 [DOI] [PubMed] [Google Scholar]
  • 23. Lasjaunias P, Berenstein A, Brugge K. Skull base and maxillofacial region. In: Surgical Neuro-angiography, 2nd ed. New York: Springer-Verlag; 2001:261–386 [Google Scholar]
  • 24. Kameda Y. Hoxa3 and signaling molecules involved in aortic arch patterning and remodeling. Cell Tissue Res 2009;336:165–78 [DOI] [PubMed] [Google Scholar]
  • 25. Suh DC, Lee SH, Kim KR, et al. Pattern of atherosclerotic carotid stenosis in Korean patients with stroke: different involvement of intracranial versus extracranial vessels. AJNR Am J Neuroradiol 2003;24:239–44 [PMC free article] [PubMed] [Google Scholar]
  • 26. Koch S, Nelson D, Rundek T, et al. Race-ethnic variation in carotid bifurcation geometry. J Stroke Cerebrovasc Dis 2009;18:349–53 [DOI] [PubMed] [Google Scholar]
  • 27. Helderman F, Segers D, de Crom R, et al. Effect of shear stress on vascular inflammation and plaque development. Curr Opin Lipidol 2007;18:527–33 [DOI] [PubMed] [Google Scholar]
  • 28. Groen HC, Gijsen FJ, van der Lugt A, et al. Plaque rupture in the carotid artery is localized at the high shear stress region: a case report. Stroke 2007;38:2379–81 [DOI] [PubMed] [Google Scholar]
  • 29. Masawa N, Glagov S, Zarins CK. Quantitative morphologic study of intimal thickening at the human carotid bifurcation, I: Axial and circumferential distribution of maximum intimal thickening in asymptomatic, uncomplicated plaques. Atherosclerosis 1994;107:137–46 [DOI] [PubMed] [Google Scholar]
  • 30. Friedman MH, Hutchins GM, Bargeron CB, et al. Correlation of human arterial morphology with hemodynamic measurements in arterial casts. J Biomech Eng 1981;103:204–07 [DOI] [PubMed] [Google Scholar]
  • 31. Doux JD, Yun AJ. The link between carotid artery disease and ischemic stroke may be partially attributable to autonomic dysfunction and failure of cerebrovascular autoregulation triggered by Darwinian maladaptation of the carotid baroreceptors and chemoreceptors. Med Hypotheses 2006;66:176–81 [DOI] [PubMed] [Google Scholar]
  • 32. Qureshi AI, Luft AR, Sharma M, et al. Frequency and determinants of postprocedural hemodynamic instability after carotid angioplasty and stenting. Stroke 1999;30:2086–93 [DOI] [PubMed] [Google Scholar]
  • 33. Nonaka T, Oka S, Miyata K, et al. Prediction of prolonged postprocedural hypotension after carotid artery stenting. Neurosurgery 2005;57:472–77 [DOI] [PubMed] [Google Scholar]
  • 34. Abou-Chebl A, Yadav JS, Reginelli JP, et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol 2004;43:1596–601 [DOI] [PubMed] [Google Scholar]
  • 35. Rothwell PM, Gibson RJ, Slattery J, et al. Equivalence of measurements of carotid stenosis: a comparison of three methods on 1001 angiograms. European Carotid Surgery Trialists’ Collaborative Group. Stroke 1994;25:2435–9 [DOI] [PubMed] [Google Scholar]

Articles from AJNR: American Journal of Neuroradiology are provided here courtesy of American Society of Neuroradiology

RESOURCES